David Jeong
Allergy & Immunology · White Plains, NYNPI 1912023565
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $47,726 of the $68,386 with a category attached, or 69.8%. 28 manufacturers reported payments, led by AstraZeneca at 55.6% of the total. Reporting peaked in 2024 at $34,137 and has fallen 80.4% since, to $6,697 in 2025. Among allergy & immunology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 422 payments — averaging $162.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$38K
- Blueprint Medicines Corporation$10K
- Novartis$7K
- Amgen$4K
- Sanofi$3K
- Biocryst US Sales Co., LLC$983
- plus $4K from 22 others
Across 38 payments — averaging $8484.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aimmune Therapeutics, Inc.$118K
- Blueprint Medicines Corporation$116K
- Novartis$88K
What the payments were for
- Consulting fees$8,12412%
- Speaking & faculty fees$47,72670%
- Travel & lodging$2,5694%
- Food & beverage$9,90414%
- Education$640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 79 | $38,015 |
| Blueprint Medicines Corporation | 24 | $10,333 |
| Novartis | 48 | $7,171 |
| Amgen | 19 | $4,425 |
| Sanofi | 10 | $3,050 |
| Biocryst US Sales Co., LLC | 58 | $983 |
| GSK | 36 | $819 |
| CSL Behring | 29 | $740 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $647 |
| Regeneron Healthcare Solutions, Inc. | 24 | $610 |
| Pharming Healthcare, Inc. | 16 | $381 |
| Grifols USA, LLC | 10 | $233 |
| Pfizer | 11 | $197 |
| Genentech USA, Inc. | 7 | $181 |
| Kaleo, Inc. | 4 | $99 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $86 |
| AbbVie | 3 | $76 |
| ADMA Biomanufacturing LLC | 3 | $63 |
| Alk-abello, Inc | 3 | $62 |
| Dermavant Sciences, Inc. | 2 | $48 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Aerin Medical Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Phadia US Inc. | 1 | $21 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$68,386 in reported general payments places this provider in the 90th percentile of 320 allergy & immunology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $13,832 |
| Ipratropium Bromide | 31 | $1,527 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $668 |
| Montelukast Sodium | 15 | $208 |
| Prednisone | 20 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $819 | $13,83219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 320 allergy & immunology providers in New York.
Other allergy & immunology in White Plains
- Ujwala KazaNew York$1.1M
- Syed MustafaRochester$948K
- Robert SporterNew York$946K
- Gregory PuglisiPlainview$813K
- Stanley GoldsteinRockville Centre$643K
- Robert TamayevRego Park$321K
- Richard InselNew York$269K
- Payel GuptaBrooklyn$256K
- Luz FonacierMineola$237K
- Mark Davis-LortonTarrytown$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.